BRPHF yields 9.20% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 6
Combined, BRPHF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BRPHF + MRK for your $10,000?
Galaxy Digital Holdings Ltd., an asset management firm, operates in the digital asset, cryptocurrency, and blockchain technology industry. It operates through five segments: Trading, Principal Investments, Asset Management, Investment Banking, and Mining. The company provides spot, derivate, and financing liquidity to institutional clients, counterparties, and venues that transact in cryptocurrencies and other digital assets; and offers access to traded cryptocurrencies to clients and counterparties across a suite of service offerings, including over-the-counter (OTC) spot liquidity provision, on- exchange liquidity provision, OTC options and trading, and bespoke lending and structured products, as well as engages in the proprietary quantitative, arbitrage, and macro trading strategies. It also manages third party capital across traditional and alternative asset classes. In addition, the company offers financial advisory services, such as general corporate, strategic, mergers and acquisitions, divestitures, and restructuring advisory services, as well as equity, debt, and project finance capital markets services to public and private clients. Further, it has a strategic focus to provide financial tools to North American miners, as well as has partnership with third-party data center providers and hosts its proprietary bitcoin mining equipment for helping to secure the Bitcoin network. Additionally, the company manages various portfolio of private investments across the digital assets industry, such as traditionally structured companies, as well as in those building digital asset networks powered and capitalized by tokens. Galaxy Digital Holdings Ltd. is headquartered in New York, New York.
Full BRPHF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.